Pillarisetty, Venu G.

Key chemokines direct migration of immune cells in solid tumors

Kohli, K., Pillarisetty, V. G., & Kim, T. S. (2022) · Cancer Gene Therapy

Chemokine receptors and signalingCancer Immunotherapy and Biomarkers

Cited by 583

γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

Daley, D., Zambirinis, C. P., Seifert, L., Akkad, N., Mohan, N., Werba, G., Barilla, R., Torres-Hernandez, A., Hundeyin, M., Mani, V. R. K., et al. (2016) · Cell

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 329

Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Henrikson, N. B., Aiello Bowles, E. J., Blasi, P. R., Morrison, C. C., Nguyen, M., Pillarisetty, V. G., & Lin, J. S. (2019) · JAMA

Pancreatic and Hepatic Oncology ResearchGlobal Cancer Incidence and Screening

Cited by 140

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer

Chen, R., Lai, L. A., Sullivan, Y., Wong, M., Wang, L., Riddell, J., Jung, L., Pillarisetty, V. G., Brentnall, T. A., & Pan, S. (2017) · Scientific Reports

Pancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and Metabolism

Cited by 92

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas

Diehl, A. C., Hannan, L. M., Zhen, D. B., Coveler, A. L., King, G., Cohen, S. A., Harris, W. P., Shankaran, V., Wong, K. M., Green, S., et al. (2022) · The Oncologist

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 35

Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial

Seo, Y. D., Lu, H., Black, G., Smythe, K., Yu, Y., Hsu, C., Ng, J., Hermida de Viveiros, P., Warren, E. H., Schroeder, B. A., et al. (2023) · JAMA Oncology

Sarcoma Diagnosis and TreatmentImmunotherapy and Immune Responses

Cited by 31